Raymond James Financial Services Advisors Inc. Acquires 365 Shares of Monsanto Company (MON)
Raymond James Financial Services Advisors Inc. raised its holdings in shares of Monsanto Company (NYSE:MON) by 0.9% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 42,401 shares of the basic materials company’s stock after acquiring an additional 365 shares during the quarter. Raymond James Financial Services Advisors Inc.’s holdings in Monsanto were worth $5,019,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other large investors have also bought and sold shares of MON. Pinnacle Financial Partners Inc. purchased a new position in Monsanto during the 2nd quarter valued at about $114,000. Bruderman Asset Management LLC purchased a new position in Monsanto during the 2nd quarter valued at about $116,000. Tower Research Capital LLC TRC increased its holdings in Monsanto by 230.1% during the 2nd quarter. Tower Research Capital LLC TRC now owns 1,076 shares of the basic materials company’s stock valued at $128,000 after acquiring an additional 750 shares in the last quarter. JNBA Financial Advisors increased its holdings in Monsanto by 3.9% during the 1st quarter. JNBA Financial Advisors now owns 1,193 shares of the basic materials company’s stock valued at $135,000 after acquiring an additional 45 shares in the last quarter. Finally, Armbruster Capital Management Inc. increased its holdings in Monsanto by 12.2% during the 2nd quarter. Armbruster Capital Management Inc. now owns 1,147 shares of the basic materials company’s stock valued at $136,000 after acquiring an additional 125 shares in the last quarter. Hedge funds and other institutional investors own 74.81% of the company’s stock.
Shares of Monsanto Company (MON) traded up 2.07% on Friday, reaching $122.39. 2,899,700 shares of the company’s stock were exchanged. The firm’s 50 day moving average price is $118.57 and its 200-day moving average price is $117.22. Monsanto Company has a 12 month low of $97.35 and a 12 month high of $122.79. The company has a market capitalization of $53.79 billion, a P/E ratio of 24.05 and a beta of 1.07.
Monsanto (NYSE:MON) last released its quarterly earnings data on Wednesday, October 4th. The basic materials company reported $0.20 EPS for the quarter, topping analysts’ consensus estimates of ($0.41) by $0.61. Monsanto had a return on equity of 42.40% and a net margin of 15.44%. The firm had revenue of $2.69 billion for the quarter, compared to the consensus estimate of $2.51 billion. During the same quarter in the prior year, the company posted $0.07 earnings per share. The firm’s revenue was up 4.8% on a year-over-year basis. On average, equities analysts anticipate that Monsanto Company will post $5.70 EPS for the current year.
The company also recently disclosed a quarterly dividend, which will be paid on Friday, October 27th. Investors of record on Friday, October 6th will be issued a $0.54 dividend. The ex-dividend date is Thursday, October 5th. This represents a $2.16 dividend on an annualized basis and a yield of 1.80%. Monsanto’s dividend payout ratio is currently 42.27%.
Several equities analysts have weighed in on the stock. Wells Fargo & Company raised their target price on shares of Monsanto from $107.50 to $118.00 and gave the company a “market perform” rating in a report on Tuesday. Barclays PLC restated an “equal weight” rating and set a $124.00 target price (up from $120.00) on shares of Monsanto in a report on Thursday, October 5th. BMO Capital Markets restated a “buy” rating and set a $128.00 target price on shares of Monsanto in a report on Thursday, October 5th. Macquarie downgraded shares of Monsanto from an “outperform” rating to a “neutral” rating in a report on Wednesday, October 4th. Finally, Jefferies Group LLC reiterated a “hold” rating and set a $128.00 price target on shares of Monsanto in a report on Friday, September 15th. Eleven investment analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. The stock currently has an average rating of “Hold” and a consensus target price of $124.61.
COPYRIGHT VIOLATION WARNING: “Raymond James Financial Services Advisors Inc. Acquires 365 Shares of Monsanto Company (MON)” was first posted by The Cerbat Gem and is the property of of The Cerbat Gem. If you are accessing this piece of content on another domain, it was stolen and reposted in violation of United States and international trademark & copyright law. The legal version of this piece of content can be read at https://www.thecerbatgem.com/2017/10/13/raymond-james-financial-services-advisors-inc-acquires-365-shares-of-monsanto-company-mon.html.
In related news, VP Duraiswami Narain sold 2,860 shares of the stock in a transaction that occurred on Monday, September 25th. The stock was sold at an average price of $120.00, for a total value of $343,200.00. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, COO Brett D. Begemann sold 22,640 shares of the stock in a transaction that occurred on Monday, September 25th. The stock was sold at an average price of $120.03, for a total value of $2,717,479.20. Following the completion of the transaction, the chief operating officer now owns 85,439 shares in the company, valued at approximately $10,255,243.17. The disclosure for this sale can be found here. Insiders sold 37,026 shares of company stock worth $4,440,341 in the last 90 days. 0.79% of the stock is currently owned by corporate insiders.
Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and digital agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.
Receive News & Stock Ratings for Monsanto Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Company and related stocks with our FREE daily email newsletter.